feed,title,long_url,short_url
Benzinga,"Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022",https://benzinga.com/general/biotech/22/09/28817082/spectrum-gets-fda-nod-for-febrile-neutropenia-candidate-sees-commercial-launch-in-q4-2022,https://bit.ly/3L9V6wz
